Incremental costs and utilities for palivizumab versus no prophylaxis using the IRST to identify moderate- and high-risk 32–35wGA infants.
收藏Figshare2023-08-10 更新2026-04-28 收录
下载链接：
https://figshare.com/articles/dataset/Incremental_costs_and_utilities_for_palivizumab_i_versus_i_no_prophylaxis_using_the_IRST_to_identify_moderate-_and_high-risk_32_35wGA_infants_/23927726
下载链接
链接失效反馈官方服务：
资源简介：
Incremental costs and utilities for palivizumab versus no prophylaxis using the IRST to identify moderate- and high-risk 32–35wGA infants.
创建时间：
2023-08-10
